Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa.

Shimakawa, Yusuke; Ndow, Gibril; Njie, Ramou; Njai, Harr Freeya; Takahashi, Kazuaki; Akbar, Sheikh Mohammad Fazle; Cohen, Damien; Nayagam, Shevanthi; Jeng, Adam; Ceesay, Amie; +11 more... Sanneh, Bakary; Baldeh, Ignatius; Imaizumi, Masayasu; Moriyama, Kazushige; Aoyagi, Katsumi; D'Alessandro, Umberto; Mishiro, Shunji; Chemin, Isabelle; Mendy, Maimuna; Thursz, Mark R; Lemoine, Maud; (2019) Hepatitis B core-related antigen (HBcrAg): an alternative to HBV DNA to assess treatment eligibility in Africa. Clinical infectious diseases. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/ciz412

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1093/cid/ciz412

Abstract

Item Type Article
PubMed ID 31102406
Elements ID 131696

Share

Download

Embargo Date: 17 May 2020

Restricted to: Repository staff only

Filename: ciz412.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

[img]

Downloads

View details

Metrics & Citations


Google Scholar